FLT3-ITD
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (1) HSE (1) | FLT3-ITD | Acute Myeloid Leukemia | Gilteritinib | |
| EMA (1) FDA (1) HSE (2) | FLT3-ITD | Acute Myeloid Leukemia | Cytarabine, Daunorubicin, Midostaurin | |
| HSE (1) | FLT3-ITD | Acute Myeloid Leukemia | Midostaurin | |
| EMA (1) FDA (1) HSE (1) | FLT3-ITD | Acute Myeloid Leukemia | Quizartinib | |
| EMA (1) FDA (1) HSE (1) | FLT3-ITD | Acute Myeloid Leukemia | Cytarabine, Daunorubicin, Quizartinib | |
| EMA (1) FDA (1) HSE (1) | FLT3-ITD | Acute Myeloid Leukemia | Cytarabine, Idarubicin, Quizartinib | |
| HSE (1) | FLT3-ITD | Acute Myeloid Leukemia | Cytarabine, Quizartinib |